FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

28880611000001104: Clobetasol 500microgram / Neomycin 5mg / Nystatin 100,000units/g cream (Ennogen Healthcare Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Mar 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
90747401000001115 Clobetasol 500microgram / Neomycin 5mg / Nystatin 100,000units/g cream (Ennogen Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
90747501000001116 Clobetasol 500microgram / Neomycin 5mg / Nystatin 100,000units/g cream (Ennogen Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Clobetasol 500microgram / Neomycin 5mg / Nystatin 100,000units/g cream (Ennogen Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Clobetasol 500microgram / Neomycin 5mg / Nystatin 100,000units/g cream (Ennogen Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Clobetasol 500microgram / Neomycin 5mg / Nystatin 100,000units/g cream (Ennogen Healthcare Ltd) Is a Generic Dermovate-NN cream true Inferred relationship Existential restriction modifier
Clobetasol 500microgram / Neomycin 5mg / Nystatin 100,000units/g cream (Ennogen Healthcare Ltd) Has active ingredient Nystatin true Inferred relationship Existential restriction modifier
Clobetasol 500microgram / Neomycin 5mg / Nystatin 100,000units/g cream (Ennogen Healthcare Ltd) Has active ingredient Clobetasol propionate true Inferred relationship Existential restriction modifier
Clobetasol 500microgram / Neomycin 5mg / Nystatin 100,000units/g cream (Ennogen Healthcare Ltd) Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Clobetasol 500microgram / Neomycin 5mg / Nystatin 100,000units/g cream (Ennogen Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Clobetasol 500microgram / Neomycin 5mg / Nystatin 100,000units/g cream (Ennogen Healthcare Ltd) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Clobetasol 500microgram / Neomycin 5mg / Nystatin 100,000units/g cream (Ennogen Healthcare Ltd) Has specific active ingredient Clobetasol propionate true Inferred relationship Existential restriction modifier
Clobetasol 500microgram / Neomycin 5mg / Nystatin 100,000units/g cream (Ennogen Healthcare Ltd) Has specific active ingredient Neomycin sulfate true Inferred relationship Existential restriction modifier
Clobetasol 500microgram / Neomycin 5mg / Nystatin 100,000units/g cream (Ennogen Healthcare Ltd) Has specific active ingredient Nystatin true Inferred relationship Existential restriction modifier
Clobetasol 500microgram / Neomycin 5mg / Nystatin 100,000units/g cream (Ennogen Healthcare Ltd) Has dispensed dose form Cream true Inferred relationship Existential restriction modifier
Clobetasol 500microgram / Neomycin 5mg / Nystatin 100,000units/g cream (Ennogen Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Clobetasol 500microgram / Neomycin 5mg / Nystatin 100,000units/g cream (Ennogen Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Clobetasol 500microgram / Neomycin 5mg / Nystatin 100,000units/g cream (Ennogen Healthcare Ltd) 30 gram Has AMP True Clobetasol 500microgram / Neomycin 5mg / Nystatin 100,000units/g cream (Ennogen Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start